The HighWire Episode 400: W.H.O.’S TO THANK Links & Notes
https://thehighwire.com/ark-videos/w-h-o-s-to-thank/
This Episode covers the W.H.O. Global Vaccine Safety Summit, December 2-3, 2019
https://www.who.int/news-room/events/detail/2019/12/02/default-calendar/global-vaccine-safety-summit
The excerpts are from this HighWire episode
Episode 145: WHO IS LYING TO YOU?
https://thehighwire.com/ark-videos/who-is-lying-to-you/
1:30 400th episode
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
2:39 VAXXED
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
https://vaxxedthemovie.com/
Available free here
https://thehighwire.com/ark-videos/vaxxed-from-cover-up-to-catastrophe/
VAXXED II
https://live.childrenshealthdefense.org/chd-tv/videos/vaxxed-2/
VAXXED III
2:53 Aaron Siri, ESQ; Lead Counsel, ICAN Legal Team
3:08 1986 Act
https://www.hrsa.gov/sites/default/files/hrsa/vicp/title-xxi-phs-vaccines-1517.pdf
https://www.hrsa.gov/vaccine-compensation
3:37 Legal wins page
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
4:30 WHO Vaccine Safety Summit
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
https://www.who.int/news-room/events/detail/2019/12/02/default-calendar/global-vaccine-safety-summit
This meeting was meant to figure out how to stop vaccine hesitancy.
4:43 Global Advisory Committee on Vaccine Safety (GACVS)
5:58 MAHA RFK JR
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
7:22 Maybe they decide it was time for adult mandates
8:07 3 months after this summit Covid pandemic hit
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
8:31 START PRERECORDED Episode 145 WHO IS LYING TO YOU
Episode 145: WHO IS LYING TO YOU?
https://thehighwire.com/ark-videos/who-is-lying-to-you/
8:39 Dr Heidi Larson, MA PhD; Anthropologist, Director of The Vaccine Confidence Project
9:16-10:38 Dr Larson presentation social media
Day 2, Dec 3, 2019 Tuesday Afternoon, second part
Timestamp: 1:14:53
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“We’ve seen, ah, ah, a lot of news about the growing questioning environment, but what I’m trying to look at here is where does safety come up in the broader look at where the confidence problem is. And again, and again safety rises to the top. This is in the US. Um, ah, I’ve done a lot in the, in Europe. Wm, this was our first. Uh, we developed a vaccine confidence index, which we’ve been running for five years. Ah, we’re have under review now an analysis of two hundred fifty thousand [250,000] people on a hundred forty-eight countries. Un, we have all their background demographics and um, to look at what are the trends and patterns.”
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“But this is one of the first one’s we did, sixty-seven countries in 2016. And I was actually surprised at Europe being so acutely skeptical when it came to safety. I knew other countries were having some issues but uh, um, it was quite um, acute in Europe.”
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Ah, when we try to disaggregate that by different kinds of reasons, safety is the, is the biggest issue.”
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Safety is the biggest issue. Fear of side effects. Low sense of risk.”
12:32 Lack of vaccine confidence reasons
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
13:27-14:12 Healthcare providers have concerns too
Day 2, Dec 3, 2019 Tuesday Afternoon, second part
Timestamp: 1:16:22
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“The other thing that’s a trend and an issue is not just confidence in providers but confidence of healthcare providers. We have a very wobbly health professional front line that is starting to question vaccines and the safety of vaccines. That’s a huge problem because to this day, any study I’ve seen and we’re constantly looking on any studies on, in this space, still the, the most trusted person on any study I’ve seen globally is the healthcare provider. And if we loss that, we’re in trouble.”
14:25 Vaccine Safety White Paper
Introduction To Vaccine Safety And Policy In The United States
https://icandecide.org/article/introduction-to-vaccine-safety-and-policy-in-the-united-states/
White Paper
https://icandecide.org/wp-content/uploads/2019/09/VaccineSafety-Version-1.0-October-2-2017-1.pdf
An Introduction to Vaccine Safety
https://icandecide.org/article/an-introduction-to-vaccine-safety/
https://icandecide.org/wp-content/uploads/2023/08/INTRO_TO_VAX_SAFETY_2023.pdf
15:35-16:06 Doctors are barely trained about vaccines
Day 2, Dec 3, 2019 Tuesday Afternoon, second part
Timestamp: 1:17:09
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“We’ve talked about it earlier some of the challenges are when the frontline ah, professionals are starting to question or they don’t feel like they have enough confidence about the safety to stand up to it to the person asking them the questions. Most medical school curriculums, even nursing curriculums, I mean in medical school your lucky if you have a half day on vaccines, never mind keeping up to date with all this.”
17:06-17:40 AIMS skit How to Stop and Anti-vaxxer
How to Stop and Anti-vaxxer skit
https://x.com/HighWireTalk/status/1695500279695757678
Mother confronts doctor about what he knows about vaccines in a skit.
Transcript NOTE: This is satire. As with most humor, there is a giant kernel of truth here.
[Doctor]:
“You are concerned that I don’t know the ingredients in the vaccines that we’re gonna be giving your baby today?”
[Mother]:
“[foul-word redacted] right I am. Vaccinating is what you’ve been doing for what, twenty years? You don’t know the ingredients?”
[Doctor]:
“So what?”
[Mother]:
“I could go into any restaurant in the state and the server could tell me every ingredient of every dish on the menu of like fifty things and that person probably didn’t even go to college. And you went to medical school for eight years and you can’t tell me one ingredient in six vaccines?”
[Doctor]:
“The product is safe. That’s what I know. That’s all that matters.”
[Mother]:
“SAFE?”
[rest of Doctors in the room]:
“And effective!”
19:16-20:30 Truth that spreads doubt
Day 2, Dec 3, 2019 Tuesday Afternoon, second part
Timestamp: 1:34:34
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“I spend a lot of time talking, particularly in the last six months, ah, with tech companies, Facebook, Whatapp, Pulsar, Twitter, Instagram, Wechat, Weibo, they have a lot of fingers pointing at them to fix the misinformation problem. But it’s not so simple. One, the biggest problem is a lot of it’s not misinformation.”
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Our problem is as we’ve heard in the last forty-eight hours, that there’s not anything 100 percent. And what actually can legally without creating a censorship thing, can we absolutely say, ‘This is misinformation?’ Because we have a lot of ambiguity in the safety field. And we have to come to terms with that.”
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, we have to think about it differently than deleting misinformation. But building trust so people are willing to put up with a certain amount of risk because they believe in it enough. They believe in ug, our work, what we’re doing, and that it’s in their interest.”
20:34 Del comments
Del: “What she’s saying is: Look, we all have to admit that our biggest problem is these things that are being said in these blogs and these posts online – it’s not actually misinformation. … Even though we’ve told CNN to call it misinformation, even though we told the Washington Post, the New York Times to call it misinformation, here inside this room where we forgot the cameras are rolling, we all know deep down it’s not misinformation. It’s true. They found our weakness. We have a real problem now. And we’re losing the people. Somehow their getting the information. Somehow this problem is growing.”
21:46 Vaccine Safety White Paper
Introduction To Vaccine Safety And Policy In The United States
https://icandecide.org/article/introduction-to-vaccine-safety-and-policy-in-the-united-states/
White Paper
https://icandecide.org/wp-content/uploads/2019/09/VaccineSafety-Version-1.0-October-2-2017-1.pdf
22:21-23:57 Power of social media to spread information
Day 2, Dec 3, 2019 Tuesday Afternoon, second part
Timestamp: 1:46:42
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“This is a, a physicist I’m working with at GW in George Washington University is actually an Oxford um, ah, physicist. These are, he is had worked primarily on different kinds of social networks. But I was fascinated by his methods and I said, ‘listen you should look at the vaccine space. So, each of these blobs as he calls them um, are communities. Like a Facebook page which uh are in a code, this group of mothers.”
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, the green dots are undecided, neutral communities, people interested in vaccines but asking questions. Um, the red are the ah clearly questioning anti communities. And the blue are the positive. Already, you can see the blue is a tighter group and the red more out there. Now, if you look at the numbers, what he was looking at was over a period of time literally a couple months, what is the recruiting pace of the blue positive verses the red in them converting the undecided to their camp or the other?”
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“It was a five hundred percent faster recruitment by the negative um, than the positiveah vaccine community. That’s fast. And these are not, this is not hypothetical.”
23:57 Del is pleased with this information
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
25:30-26:05 Get rid of the term anti-vax
Day 2, Dec 3, 2019 Tuesday Afternoon, second part
Timestamp: 1:30:40
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Our biggest, one of our biggest challenges, I think now, is getting rid of the term anti-vax. Getting rid of the hostile language. And starting to have more conversations, to be open to questions, to make people feel like they shouldn’t be judged when they are asking questions, as crazy as those questions might seem to you, as stupid as they might seem, or as ignorant as they might seem, ah, we can’t risk losing another person’s confidence in safety right now.”
26:17 Stanley Plotkin, M.D.; World’s Leading Authority on vaccine
26:28 Dr Paul Offit, MD; Director of the Vaccine Education Center, The Children’s Hospital of Philadelphia
26:30 Richard Pan; (D) CA State Senator
27:22 Dr Richard Pan Facebook post about Bigtree
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Facebook post
29:02 HERD IMMUNITY
29:48 Natural immunity from mothers last to 1 & ½ years
30:05 Vaccinated mothers pass zero immunity to their babies
31:51-32:36 Humans are vaccine dependent now
Day 2, Dec 3, 2019 Tuesday Afternoon, second part
Timestamp: 1:29:52
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“I think that one of our biggest challenges is, as, as Bob said this morning, yesterday, we’re in a unique position in human history where we’ve shifter ah, the human population to vaccine induced um, to dependency on vaccine induced immunity. And that’s on the great assumption that populations would cooperate. And for many years, people lined up. The six vaccines. People were there. They saw the reason.”
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“We’re in a very fragile state now. We have developed a world that is dependent on vaccinations. We don’t have a choice but to make that effort.”
34:00 If vaccines are safe, what harm does this do
34:37-35:11 Vaccine safety science needs work
Day 2, Dec 3, 2019 Tuesday Afternoon, second part
Timestamp: 1:52:00
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Heidi Larson, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“There’s a lot of safety science that’s needed. And um, ah, uh, without the good science we can’t have good communication. So, although I’m talking about all these other contextual issues, and communication issues, it absolutely needs the science as the backbone. You can’t repurpose the same old science to make it sound better if you don’t have the science that’s relevant to new problem. So, we need much more investment in safety science.”
37:40 Del explain they have no science to back up safety claims
36:15 What do the other scientists think about safety
36:39 Dr Marion Gruber; Director, Office Of Vaccines Research And Review Center For Biologics Evaluation And Research, FDA
36:52-38:17 WILL NEED to improve risk management
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 19:01
[Dr Marion Gruber, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“My name is Marion Gruber. I’m with the Office Of Vaccines at the Center For Biologics Evaluation And Research, US Food and Drug Administration. And as I was reading the paper that I was part of writing, I would like to sort of underscore a few points made in that paper and also reflect on some of the issues presented to us regarding novel vaccine platforms.”
[Dr Marion Gruber, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, I think vaccines regardless whether they are generated using new and innovative technology or whether more standard uh, conventional are applied, they do require safety surveillance and monitoring that is specifically tailored to the vaccine that is under consideration using available pharmacovigilance systems. So, in other words, the risk management plan for each particular vaccine will need to take into the consideration the prelicensure safety database, potential safety signals that may have been identified during prelicensure clinical safety trials, other perhaps even theoretical safety concerns. And also need to take into consideration um, the disease to be prevented, the target population, and the proposed indication in order to really inform risk management.”
DEL paraphrased: We WILL NEED to do … WILL NEED, it is terrifying. That video would have been cool in 1920. It would have been cool in 1961 before they released the MMR vaccine before we got into this “world dependent on vaccines”.
39:56 Battle of Trenton
Part 1
BATTLE OF TRENTON: PART 1
https://thehighwire.com/videos/battle-of-trenton-part-1/
Part 2
BATTLE OF TRENTON: PART 2
https://thehighwire.com/videos/battle-of-trenton-part-2/
Part 3
BATTLE OF TRENTON: PART 3
https://thehighwire.com/videos/battle-of-trenton-part-3/
40:17 Plane being built as it’s being flown analogy
These people are literally flying a plane AND trying to build it as it’s in the air and keep it from crashing while it is flying.
41:10 ADJUVANTS
41:52 Dr Martin Howell Friede; Coordinator, Initiative for Vaccine Research, WHO
42:00-44:39 Dangers of adjuvants in vaccines
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 14:48
[Dr Martin Howell Friede, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“I’ll just say a few words about adjuvants. So, adjuvants are added to vaccines for many reasons but primarily to make the vaccines work. And as we enter the next decade, we’re trying to make vaccines against malaria, TB, HIV, GBS, RSV, it is extremely likely that these are going to require adjuvants.”
[Dr Martin Howell Friede, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“And yet, every time we add an adjuvant to a vaccine, the people that are using the vaccine look at it and if there’s an adverse event, we know what they are going to say. ‘It’s the adjuvant that caused that adverse event.’ We’ve seen clinical studies in the past where a single adverse event has been blamed on the adjuvant in the development trials. And things come to a standstill while we go in and spend many years trying to investigate. Is the theoretical immune stimulation produced by that adjuvant responsible for the adverse event?”
[Dr Martin Howell Friede, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Now, over the years of GAKS (sp) over the last fifteen years, we’ve seen many accusations. I am going to begin up with Aluminum. So, this was accused of causing um, myo, macrophagic myofasciitis. And yet, this complex word typically only occurs many years a potential administration of the aluminum.”
…
[Dr Martin Howell Friede, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“And as we go forward with the immunostimulantors like NPL, like sapiens, we are likely to see every time that there is an association, be it temporal or not temporal, the first accusation is, ‘It is the adjuvant.’ And yet, without adjuvants we are not going to have the next generation of vaccines. And many of the vaccines that we do have branching from tetanus through to HPV require adjuvants in order for them to work.”
[Dr Martin Howell Friede, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, the challenge that we have in front of us is, how do we build confidence in this? And the confidence comes first of all from the regulatory agencies. To Marion [gestures toward Dr Marion Gruber. When we add an adjuvant, it’s because it is essential. We do not add adjuvants to vaccines because we want to do so. But when we add them, it in, it adds to the complexity. And I give courses every year on how do you develop vaccines, how do you make vaccines. And the first lesson is, while your making your vaccine, if you can avoid using an adjuvant, please do so. Lesson two is, if you’re going to use an adjuvant, use one that has a history of safety. And lesson three is, if you’re not going to do that, think very carefully.”
Listen to this man: “We wouldn’t’ put adjuvants in vaccines if we didn’t have to. We have to put these dangerous things into vaccines because it’s the only way we’ve figured out to make them work.”
44:56 vaccines can’t be safe because adjuvants are not safe
45:42 Prof Christopher Exley, PhD; Professor in Bioinorganic Chemistry, Keele University Honorary Professor, UHI Millennium Institute
45:45 Aluminium in brain tissue in autism
https://www.sciencedirect.com/science/article/pii/S0946672X17308763
46:07 Dr Romain K Gherardi; Neuromuscular Pathologist University of Paris-Est
46:12 Macrophagic myofasciitis: characterization and pathophysiology
https://journals.sagepub.com/doi/10.1177/0961203311429557
https://pmc.ncbi.nlm.nih.gov/articles/PMC3623725/
47:31 Dr Stephen Evans; Professor of Pharmacoepidemiology
47:38-48:42 Adjuvant multiply incidence of adverse reactions
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 40:57
[Dr Stephen Evans, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“It seems to me that adjuvants multiply the immunogenicity of the antigens that they are ah, added to, that is their intention. It seems to me they multiply the reactogenicity in many instances. And therefore, it seems to me that it is not unexpected if they multiply the incidence of adverse reactions that are associated with the antigen but may not have been detected through lack of statistical power in the original studies. Now, I wonder if this thinking is correct. And if it is, whether this has some implications for the way we do pharmacovigilance. Because one vaccine that is, has one antigen and an adjuvant and another vaccine that has a different antigen and no adjuvant, the reason for the difference is not immediately obvious.”
DEL: “If this adjuvant ramps up the power of the antigen, then it can ramp up anything else it comes in contact within the body. What about giving another vaccine at the same time that does not need an adjuvant. It could ramp up the amount of autoimmune disease in the future…. Is it possible they could ramp up the immune system in the future in a way that we do not want?”
49:41-51:21 Answer – we don’t have the data
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 42:14
[Dr Martin Howell Friede, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, with, with the local reactogenicity, you are correct. Um, as we add adjuvants, especially some of the more recent adjuvants such as the ASO-1 sapien derived adjuvants, we do see increased local reactogenicity. The primary concern those, usually is systemic adverse events rather than local adverse events. And we, we tend to get in the phase two and the phase three studies quite good data on the local reactogenicity. Those of us in this room that are beyond the age of fifty who’ve had the pleasure of having the recent shingles vaccine will know that this does have quite significant local reactogenicity. If you got the vaccine, you know that you got the vaccine.”
[Dr Martin Howell Friede, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Ah, but this is not the major health concern. The major health concern which we are seeing are accusations of long-term, long-term effects. So, what we have to bear in mind is that we don’t use adjuvants by themselves. The adjuvant is used in combination with an antigen. And an adjuvant may be, give quite different responses depending on which antigen it is combined with. So, the fact that an adjuvant is shown to be safe with one antigen might give a different response with anther antigen because of other things that are with it that act with that second antigen including impurities.”
[Dr Martin Howell Friede, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, to come back to this I’m going to once again point to the regulators. It comes down to ah, um, ensuring that we, we conduct the phase 2 and phase 3 studies with adequate size and with the ad, appropriate measurement.”
53:21 Chronic illness vs vaccine schedule chart
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Bethel et.al, 2011, A national and State Profiles of Leading Health Problems and Health Car Quality for US children: Key Insurance Disparities and Across-State Variations, Academic Pediatrics
https://www.academicpedsjnl.net/article/S1876-2859(10)00250-0/fulltext
Cleave er. Al, 2010, Dynamics of Obesity and Chronic Health Conditions Among Children and Youth, JAMA
https://jamanetwork.com/journals/jama/fullarticle/185391
53:46-56:00 They don’t know how adjuvants work
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 43:55
[Dr Martin Howell Friede, PhD, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Doing surveillance is necessary. But coming, understanding how these things work is also necessary. So that we can access plausibility”
[Dr David Kaslow, MD, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, in our clinical trials we are actually using relatively small sample sizes. And when we do that, we’re at risk of tyranny of small numbers which is, you just need a single case of Wegener's granulomatosis, and your vaccine has to solve Walt’s how do you prove a null hypothesis? And it takes years and years to try to figure, to figure that out. So, it’s a real conundrum. Right, getting the right, the right size, dealing with the tyranny of small numbers, making sure that can [garbled]. And so I think one of the things that we really need to invest in are kinda better biomarkers, better mechanistic understanding of how these things work so we can better understand um, adverse events as they come up.”
…
[Dr Marion Gruber, PhD, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“One of the additional issues that complicates safety evaluation is if you look at and you struggle with the length of follow up that should be adequate in a say prelicensure or even post marketing study if that’s even possible. Because I mean one has to acknowledge the longer you follow up, the more you perhaps see adverse events that have nothing to do with the adjuvant vaccine combination. But maybe again coincidental. But the problem is you know how do you deal with that data. And again, as you mentioned prelicensure clinical trials may not be powered enough.”
…
[Dr Marion Gruber, PhD, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“It’s also the subject population that you administer the adjuvant to. Because we’ve seen data presented to us where an adjuvant a particular adjuvant added to a vaccine antigen did really nothing when administered to a certain population. And it’s usually the elderly. You know, compared to, to administering the same formulation to younger age strata., So, these are the things which ah need to be considered as well and further complicate safety and effectiveness of adjuvants combined with vaccines antigens.”
DEL: “It’s like watching third graders in charge of our health…. This is so far from settled science it is shocking.”
56:56 Dr David Kaslow, MD; V.P., Essential Medicines, Drug Development Program PATH Center for Vaccine Innovation and Access (CVIA)
59:28 Length of testing for childhood vaccines chart
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
1:00:09 Back to live show
1:00:27 Aaron Siri talks Hep B
Episode 399 November 21, 2024; Episode 399: FACE THE FACTS, https://thehighwire.com/ark-videos/face-the-facts/
Episode 225 July, 2021; Episode 225: THE COVID BLAME GAME, https://thehighwire.com/ark-videos/the-covid-blame-game/
1:00:53 Hep B given on day one
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
CDC childhood vaccine schedule
https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html
Straight to chart
Given on day one for a disease that you catch only if you share IV needles or have promiscuous sexual relationships with multiple partners. Why is a baby getting it? It makes no sense at all.
1:01:23 LEGAL UPDATE HEP B
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
1:01:35 ACIP Hep B
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Vaccines Provided by the VFC Program
Choose Hepatitis B 6/19-3 Hepatitis B Updated Jul 2019
https://www.cdc.gov/vaccines-for-children/downloads/2019-6-3-hepb-508.pdf
“a single antigen hepatitis B vaccine (ENGERIX-B or RECOMBIVAX HB) can be given at birth.”
1:01:39 4 or 5 days monitoring
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
“…infants and children (up to 10 years of age) who were monitored for 5 days after each dose.”
Hep B Engerix-B package insert
https://www.fda.gov/media/119403/download
Hep B Recombivax package insert
1:01:49 1986 Act
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
https://www.hrsa.gov/sites/default/files/hrsa/vicp/title-xxi-phs-vaccines-1517.pdf
1:02:12 Parents decide against Hep B for newborn
Parents study the issue and decide against Hep B for their newborn baby. They write up a birth plan or clearly state they refuse the Hep B shot. The hospital injects their baby against their wishes – violating consent.
Why would hospitals do this? They consider it the “standard of care”.
1:02:16 CDC Hep B recommendation
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Hepatitis B Vaccine Administration
https://www.cdc.gov/hepatitis-b/hcp/vaccine-administration/index.html
“The Advisory Committee on Immunization Practices (ACIP) recommends hepatitis B (HepB) vaccination among all infants at birth …”
1:02:26 Childhood vaccination schedule
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Child and Adolescent Immunization Schedule by Age
https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html
straight to chart
https://www.cdc.gov/vaccines/hcp/imz-schedules/downloads/child/0-18yrs-child-combined-schedule.pdf
1:02:32 Stop Hep B vax without consent
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
https://icandecide.org/article/stop-hep-b-vaccination-without-consent/
1:02:53 END LEGAL UPDATE
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
1:02:54 Del discusses this violation of informed consent
We can’t wait for the government to do something about this violation of informed consent. One big lawsuit against one of these hospitals will have them all stop and take more care to follow informed consent.
1:03:41 Donation campaign
That takes money from donors like you. Become a recurring donor today. The HighWire is totally donation supported. There are no corporate sponsors.
1:04:08 BREAKING: ICAN Supports Lawsuits Against Healthcare Providers Who Give Newborns a Hep B Vaccine Without Parental Consent
1:04:24 2 million match campaign
This is a perfect time to donate because there is a donor who will match every dollar up to 2 million dollars. This applies to all money donated before the end of the year.
1:04:36 2 million match campaign update
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
ICANDECIDE.ORG/LEGALMATCH
https://secure.anedot.com/informed-consent-action-network/twomilmatch
Donate today and when you see that they have stopped this horrible practice, you can say, “I was part of that.”
1:06:34 HighWire black Friday sale till Monday Dec 2, 2024
https://thehighwire.shop/
1:07:39 Back to prerecorded video
1:07:40 days of monitoring vaccines
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Drugs are tested for YEARS. Vaccines are tested for DAYS. How does that make any sense? Vaccines have living antigens that are designed to spread. And they are claiming that shorter testing periods make sense?
1:10:49 PREGNANT WOMEN – NEW TARGET POPULATION
1:10:50-1:11:37 Pregnant women are untapped source
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 46:59
[Dr David Kaslow, MD, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Coming down the pike um, maybe relatively quickly is a new target population for us in vaccines. And that’s maternal immunization. And these are um, women who are pregnant who will have all kinds of adverse events associated with their pregnancy.”
[Dr David Kaslow, MD, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Part of the problem is, is that we don’t have a strong enough pharmacoepidemiologic baseline in the target populations that we’re studying to be able to say, ‘Is this an expected adverse event due to pregnancy? Or is this related to the vaccine?’ So, I do think an investment in that kind of epidemiologic base line is going to be critically important if we don’t want to derail some of our maternal immunization vaccines as they go into low resource settings.”
pharmacoepidemiologic = “Pharmacoepidemiology is a scientific discipline that uses epidemiological methods to evaluate the use, benefits and risks of medical products and interventions in human populations. To accomplish this study, pharmacoepidemiology borrows from both pharmacology and epidemiology.”
1:11:39 Del explains
We know adjuvants work differently in the elderly compared to children. What about a fetus?
They used to say, “get a pregnancy test BEFORE you get a vaccine” because the one thing we know we don’t want to do is give you a vaccine after you are pregnant.
1:12:43 CDC Advertising vax to pregnant women
1:13:26-1:13:49 ACIP Pregnant women use is off label
October 2017 ACIP Meeting - Adult Immunization ; Child/Adolescent Immunization ; JE vaccine
HighWire timestamp 1:13:26 YouTube timestamp 19:59
TRANSCRIPT
[Nana Bennett; October 2017 ACIP Meeting - Adult Immunization ; Child/Adolescent Immunization ; JE vaccine]:
“Dr. Sun”
[Dr. Wellington Sun, FDA; October 2017 ACIP Meeting - Adult Immunization ; Child/Adolescent Immunization ; JE vaccine]:
“Yes, I just want to make a clarification on the use of vaccines in pregnancy. Unless there's a study of that vaccine in pregnant women, ah, even though that age indication, you know, may fall within that age indication, it's still not considered, still, use in pregnant women would still be considered off label.”
1:13:56 Del is sitting behind the doctor who is speaking
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
1:13:05 Del explains
ICAN FOIA’d the FDA for the trials using pregnant women. The FDA had no studies at all using pregnant women.
1:14:31 ICAN FOIA for flu studies in pregnant women
Stipulated Order Showing FDA’s Off-Label Use of Vaccines During Pregnancy
Stipulated Order Showing FDA’s Off-Label Use of Vaccines During Pregnancy
Order
https://icandecide.org/wp-content/uploads/2019/09/ICAvFDA-Resolved-Court-Filed-Copy.pdf
https://icandecide.org/wp-content/uploads/2019/11/ICAN-v-FDA-Resolved-Court-Filed-Copy-Copy.pdf
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
“These requests sought the clinical trials relied upon by the FDA prior to approving any currently licensed influenza or Tdap vaccine for use in pregnant women as an indicated use. … We have no records responsive to your requests.”
1:15:30 This is Del’s dream moment
1:16:22 WOBBLY CONFIDENCE OF DOCTORS AT THE CONFERENCE
1:16:50-1:18:21 Dr Okposen interaction of adjuvants
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 52:00
[Dr Bassey Okposen, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“As we’re having these discussions, something was just going through my mind, in which I will need clarification. Outside vaccines, for instance we take [garbled] each other and there are so many other drugs like that.
[Dr Bassey Okposen, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“I cast back my mind to our situation in Nigeria, where at six weeks, ten weeks, fourteen weeks, a child is being given different antigens from different companies, and these vaccines have different adjuvants, different preservatives, and so on… We go again to nine months… Currently the child at nine months will receive maybe eight. That same child will receive yellow fever. That same child will receive measles vaccine.”
[Dr Bassey Okposen, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Something crosses my mind… Is there a possibility of these adjuvants, preservatives, cross-reacting amongst themselves? Has there ever been a study on the possibilities of cross-reactions, [garbled] that you can share the experience with us? Because this is one thing that is also crossing my mind, going back home. This is an area that will need to work with the regulatory agency. Let’s even see what is happening. Is there any possibility?”
[Dr Bassey Okposen, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, we’ll need guidance from the panel members whether there has ever been any study on these cross-reactions, of multiple antigens from different companies given to each other at the same time. What counsel do you have for us? Thank you.”
1:19:07 ACIP says different limbs
February 21, 2018 ACIP Meeting - Hepatitis Vaccines
YouTube Timestamp 48:03
[Unidentified male speaker at ACIP meeting October 2017]:
“Is there any comment on using this vaccine the same time with other adjuvanted vaccines?”
[Unidentified female speaker at ACIP meeting October 2017]:
“We have no data to, uh, make, um, a recommendation one way or the other.”
[Unidentified female speaker at ACIP meeting October 2017]:
“So, um …just so you … just to sort of put this in context of other vaccines, um, whilst pre-clinical studies were not done using these vaccine simultaneously, our general approach to immunizations is that, um, they should be given … they can be given at the same time in different, um, limbs.”
1:19:39 Del reacts
1:19:47 Dr Bassey Okposen; Program Manager, National Emergency Routine Immunization Coordination Centre (NERICC), Abuja, Nigeria
1:20:15-1:23:06 WHO answer is combo safe
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 53:40
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
[Dr Robert Chen, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“This is a very important question. Ah, because in general the clinical trials with any particular new product ah, frequently is done ah, just by itself. And then ultimately, frequently, the regulators will ask if that vaccine could be added to the routine immunization program. And so for if we’re going, a trial is done with that new vaccine ah, in addition to the regular ah, regiment.”
[Dr Robert Chen, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“But your question is almost kind of the next step. Ah, because in real practice frequently there multiple vaccines from different manufacturers that they maybe receive at a different age schedules etcetera. And if you take a look at the um, immunization schedule over the last, ah, let’s say fifteen twenty years in high income countries um, as well as in low resource countries, ah the schedule has gotten more and more complex. And so, if you take a look at the um, exposure, what we call the vaccine exposure in the typical adverse event report to a spontaneous reporting system in any country, you’ll see that increase in heterogeneity of those different vaccine exposures especially if you take the manufacturer into account.”
[Dr Robert Chen, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Now the only way to tease that out is if you have a large population database like the Vaccine safety Datalink as well as some of the other national databases that are coming to be worthy, actual vaccine exposure is tracked down to that level of specificity of who is the manufacturer. What is the lot number? Etcetera etcetera. And, and there’s initiative to try to make the ah, vaccine label information bar coded so that it includes that level of information so that in the future, when we do these type of studies, we are able to tease that out.”
[Dr Robert Chen, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“And in order to be, each time you subdivide then the sample size gets becoming more and more challenging. And that’s what I said earlier today about that we’re really only in the beginning of the era of large datasets where hopefully you could start to ah, kina, ah, harmonize the databases for multiple studies. Ah, there actually ah, ah, initiative under way ah, Helen, there, ah, ah, ah may want to comment on it to try to get more national vaccine safety database ah linked together so we could start to answer these type of questions that you just raised.”
DEL: That was a lot of words to get to “So we can START TO ANSWER THESE TYPES OF QUESTIONS”.
1:23:10 Del summarizes and comments
DEL: That was a lot of words to get to “So we can START TO ANSWER THESE TYPES OF QUESTIONS”. These are the professionals saying these things are not tested in their own voice.
Here are things he said in Del’s words:
“Your question leads us to the next step. The step we haven’t gotten to. The step we should have gotten to before we started trying to fly this place before it was built.”
They give so many at a well-baby visit that there’s no way to isolate which one is causing problems.
The answer is the studies have not been done. There are not studies showing that combining all these shots with the different antigens and adjuvants and manufacturers is in any way safe.
1:25:46 childhood schedule no studies have been done
The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies (2013)
https://nap.nationalacademies.org/read/13563/chapter/2#5
Full Book
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
See chapter 2
Page 6
“…studies designed to examine the long-term effects of the cumulative number of vaccines or other aspects of the immunization schedule have not been conducted.”
Page 6
“…existing research has not been designed to test the entire immunization schedule.”
Page 5-6
“No studies have compared the differences in health outcomes … between entirely unimmunized populations of children and fully immunized children.”
National Academies of Sciences, Engineering, and Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. https://doi.org/10.17226/13563
1:26:25 WHO public safety claims vs meeting
1:26:43-1:28:01 WHO commercial - vaccines are safe
WHO works to ensure vaccinations are safe
YouTube timestamp: 1:02
Transcript
[Dr Soumya Swaminathan, WHO chief scientist]:
“Vaccines are very safe. If someone gets sick after vaccination, it is usually either a coincidence, an error in administering the vaccine, or very rarely a problem with the vaccine itself. That's why we have vaccine safety systems. Robust vaccine safety systems allow health workers and experts to react immediately to any problems that may arise. They can examine the problem. Rigorously and scientifically look at the data. And then promptly address the problem. WHO works closely with countries to make sure that vaccines can do what they do best prevent disease without risks. New vaccines against malaria, meningitis, and encephalitis in Asia and Africa are now being thoroughly monitored with support from WHO. Vaccines are one of the safest tools we have to prevent disease and ensure a healthy future for all children.”
1:28:02 Del major points
Do they know? Did Dr Soumya Swaminathan know when they made this commercial? Or did she only learn about the abysmal state of vaccine safety during the meeting?
“Vaccines is one of the safest ways we can make you healthy here in India.”
“Even if there is an issue, you should know we have a robust vaccine safety surveillance program in place. So, if there’s any issue, we catch it right away. And we’re able to make the changes so that we can ensure to you that all these new vaccines we’re telling you, you need that they are perfectly safe.”
“Everything’s monitored by the World Health Organization and vaccines are one of the safest things, best studied products we have for your health.”
What does she say four days later at this meeting?
1:28:28 Dr Soumya Swaminathan; Chief Scientist, W.H.O.; Pediatrician
1:30:06-1:31:23 Dr Swaminathan there are no safety systems in place
Day 2, Dec 3, 2019 Tuesday Afternoon, first part
Timestamp: 29:15
[Dr Soumya Swaminathan, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“I think we cannot overemphasize the fact that we really don’t have very good safety monitoring systems in many countries. And this adds to the miscommunication and the misapprehensions because we’re not able to give clearcut answers when people ask questions about the deaths that have occurred due to a particular vaccine. And this always gets blown up in the media. One should be able to give a, a very factual account of what is happening and what the cause of deaths are. But in most cases, there’s some obfuscation at that level. And, and therefore, there’s less and less trust then in, in the system.”
…
[Dr Soumya Swaminathan, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“Putting in place the mechanisms whether they’re cohort studies or whether they’re sentinel surveillance sites to be able to, ah to monitor ah what’s going on and report back. And then for corrective action to be taken because unexpected things could arise after introduction. And one always has to be prepared. As we’ve seen in the history of many drugs, you’ve heard about, I mean learnt about adverse events only after the drugs been licensed and introduced into the population.”
[Dr Soumya Swaminathan, W.H.O. Global Vaccine Safety Summit, December 2-3, 2019]:
“So, I think that risk is always there. And the population needs to understand that and feel confident that mechanisms are being put in place to study some of those things.”
1:31:23 Back to live show
1:31:25 Analyze what she is saying
This was in 2019. That’s five years ago.
“We need to be able to give clear cut answers when there are deaths after vaccinations. And we just don’t have the ability to do that.”
These are the leadings scientists in the world. No one is standing up and saying, “Well, we’re really good in America. We’re good in Sweden. It’s just you in India.” The truth is that nobody has a surveillance system.
Dr Robert Redfield is saying he believes long-covid is mostly just a vaccine injury.
What is a new health department going to look like? What will Robert Kennedy Jr do to fix this? He wants to put in surveillance systems.
What’s a vaccine? It “tricks” your immune system into thinking your had a disease. Tricking the immune system is an autoimmune disease. The schedule tricks the immune system 72 times. How is that good? We have the highest autoimmune disease in the world and in history.
These scientists have been lying for years. That is coming to an end.
The studies will be done. Surveillance systems will be put in place. Just tell the truth about what happens.
1:32:37 Dr Robert Redfield; Director, CDC (2018-2021)
1:32:43 Redfield long covid is vax injury Cuomo
Ex-CDC Chief Dr. Robert Redfield Reveals COVID-19 Truths
YouTube video timestamp 45:46
[Dr Redfield, Cuomo Project June 4, 2024]: “
“If you came down and visited me and interviewed my patients, you know, I you'd interview patient after patient after patient that did not have covid but are very sick. You would say very sick long covid patients. And it's all from, from the vaccine.”
1:34:28 Childhood vaccine schedule
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
https://www.cdc.gov/vaccines/hcp/imz-schedules/downloads/child/0-18yrs-child-combined-schedule.pdf
1:36:40 Margaret Mead small group of dedicated make change
Screenshot from The HighWire Episode 400: W.H.O.’S TO THANK
“Never doubt that a small group of thoughtful, committed citizens can change the world, indeed, it’s the only thing that ever has.” - Margaret Mead